Clinical trial

Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis…

NCT00108355 · US Department of Veterans Affairs, U.S. Fed · Completed

Key facts

NCT number NCT00108355
Title Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
Official title Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis
Lead sponsor US Department of Veterans Affairs, U.S. Fed
Status Completed
Phase Phase 4
Study type Interventional
Conditions Ascites, Cirrhosis
Intervention type Drug, Procedure
Interventions Albumin, Intravenous Saline Infusion (Albumin placebo), Midodrine, Oral tablet (Midodrine placebo), Octreotide LAR, Saline injection (Octreotide LAR placebo), Large Volume Paracentesis
Enrollment 29
Start date Dec 1, 2003
Primary completion Aug 1, 2010
Completion Aug 1, 2012
First posted Apr 15, 2005
Last update posted Mar 6, 2014
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies